InvestorsHub Logo
Followers 43
Posts 3438
Boards Moderated 0
Alias Born 01/18/2011

Re: nodummy post# 78441

Thursday, 10/16/2014 12:08:34 PM

Thursday, October 16, 2014 12:08:34 PM

Post# of 221910
In this filing says "KBM Worldwide Inc., an affiliate of Asher"

http://www.getfilings.com/sec-filings/140829/Revolutions-Medical-CORP_10-Q/

KBM Worldwide



On May 5, 2014, the Company issued a convertible promissory note to KBM Worldwide Inc., an affiliate of Asher, for proceeds of $38,900 (the “KBM Note”). The note is convertible to the Company’s common stock at a conversion price equal to the greater of (1) 53% multiplied by the average of the lowest three trading days for the Company’s common stock during the 10 day trading period ending on the latest completed trading day prior to the conversion date and (2) a fixed conversion price of $0.00005 per share. The Company analyzed the KBM Note for derivative accounting consideration and determined that the conversion feature of these notes qualify for accounting treatment as a financial derivative. The conversion feature of the note was valued at $32,046 on the issuance date. During the six months ended June 30, 2014, the Company recognized $6,098 of interest expense related to the amortization of the debt discount on the KBM notes. At June 30, 2014, there was $25,948 of unamortized discount related to the unconverted KBM notes with a total principal balance of $38,900.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.